At a glance
ClinicalIndex Comparison Record- ✓Age 18 years or older
- ✓Atrial fibrillation on presentation with planned direct current cardioversion
- ✕Arrhythmias other than atrial fibrillation
- ✕Hemodynamically unstable atrial fibrillation
- ✕Untreated hyperthyroidism
- ✕Known or suspected pregnancy
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pragmatic Randomized Clinical Trial Comparing Rectilinear Biphasic Waveform and Biphasic Truncated Exponential Waveform Shocks for Cardioversion of Atrial Fibrillation (Zoll vs Lifepak)
In Brief
A clinical study evaluating Zoll external defibrillator and Lifepak external defibrillator for Atrial Fibrillation. Completed, enrolled 546 participants across 1 site.
Detailed Summary
The goal of this single center, investigator initiated, open label prospective randomized controlled trial is to compare the efficacy of a single 200J RBW shock and a single 360J BTE shock. The secondary objective of the study is to compare the frequency of adverse events after one or two 200J RBW or 360J BTE shocks
Study Details
Timeline
Interventions
Patients with AF will be randomized to receive a full output synchronized 200J shock using a RBW waveform from a Zoll defibrillator
Patients with AF will be randomized to receive a full output synchronized 360J shock using a BTE waveform from a Lifepak defibrillator